29 April 2026Policy & Regulation
Purdue Pharma to pay $8 billion to end US opioid case
Purdue Pharma agreed to an $8 billion fine and guilty pleas to criminal conspiracy charges, while the Sackler family will pay $225 million in civil penalties to resolve opioid marketing allegations. The deal transitions Purdue to a "public benefit company" post-bankruptcy, continuing drug production while prioritizing overdose rescue and addiction treatment donations. Critics from 25 state attorneys general argue the settlement inadequately punishes individuals, with no criminal indictments despite outlined crimes. The resolution still requires judicial approval and leaves Sacklers vulnerable to additional claims.
From Goldman cuts AI access in Hong Kong as UAE quits OPEC